Title of article - A scorecard for tracking actions to reduce the burden of non-communicable diseases.
Abstract
Before this study started, the standard postoperative chemotherapy regimen for stage II-III Wilms' tumour pretreated with chemotherapy was to include doxorubicin. However, avoidance of doxorubicin-related cardiotoxicity effects is important to improve long-term outcomes for childhood cancers that have excellent prognosis. We aimed to assess whether doxorubicin can be omitted safely from chemotherapy for stage II-III, histological intermediate-risk Wilms' tumour when a newly defined high-risk blastemal subtype was excluded from randomisation.
CLICK HERE for Full article Click button above to go to original article link with complete article details for A scorecard for tracking actions to reduce the burden of non-communicable diseases.
Please CLICK HERE to discuss with us on facebook about this article.
Click below for Details of research Institute
Research Centre for the Prevention and Control of NCD, Institute of Nutrition of Central America and Panama, Guatemala, UK.
Details of Journal for A scorecard for tracking actions to reduce the burden of non-communicable diseases.
Journal Title - Lancet (London, England)
ISSN - 1474-547X
Volume - 386
Issue - 9999
Publish date - 2015-Sep
Language - eng
Country - England
No comments:
Post a Comment